ICON Awarded Best CRO at World Vaccine Congress 2017
ICON recognised for continually setting standards of excellence in vaccine development
Dublin, Ireland, 12 April 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded Best Clinical Research Organisation at the Vaccine Industry Excellence (ViE) Awards. ICON was presented with the award at the World Vaccine Congress which took place in Washington this week.